探索一种简短筛查措施在高级别胶质瘤患者未满足的支持性护理需求方面的临床效用。
Exploring the clinical utility of a brief screening measure of unmet supportive care needs in people with high-grade glioma.
作者信息
Campbell Rachel, Faris Mona, Shaw Joanne, Halkett Georgia K B, Legge Dianne, Koh Eng-Siew, Nowak Anna K, Agar Meera R, Ownsworth Tamara, Pike Kerryn E, Chan Raymond J, Dhillon Haryana M
机构信息
Psycho-oncology Co-operative Research Group (PoCoG), School of Psychology, Faculty of Science, University of Sydney, Sydney, NSW, Australia.
Curtin School of Nursing/ Curtin Health Innovation Research Institute, Faculty of Health Sciences, Curtin University, Bentley, WA, Australia.
出版信息
Neurooncol Pract. 2023 Jun 24;10(5):454-461. doi: 10.1093/nop/npad035. eCollection 2023 Oct.
BACKGROUND
People living with high-grade glioma (HGG) have diverse and complex needs. Screening aims to detect patients with level of unmet need requiring triaging and further assessment. However, most existing measures of unmet need are not suitable for screening in this population due to their length. We aimed to explore the clinical utility of a brief screening tool (SCNS-ST9) in people with HGG in detecting unmet needs.
METHODS
Secondary analysis of data collected in a prospective cohort study of 116 people with HGG who completed the Supportive Care Needs Survey (SCNS-SF34) and a brain cancer-specific needs survey (BrTSCNS) during chemoradiation (T1) and 6 months later (T2). The SCNS-ST9 contains a subset of 9 items from the SCNS-SF34. Data analysis determined the number of individuals with unmet needs on the SCNS-SF34 and the BrTSCNS, not identified as having some level of need by the SCNS-ST9.
RESULTS
Overall, 3 individuals (T1: 2.6% [3/116]; T2: 4.8% [3/63]) at each time point reported other unmet needs on the SCNS-SF34 that were missed by the SCNS-ST9. Domain-specific screening items missed a higher proportion of individuals (3.2%-26%), particularly in the psychological and health systems domains. Only 1 individual with brain cancer-specific needs was missed by SCNS-ST9 overall.
CONCLUSION
Findings demonstrate the sensitivity and clinical utility of a brief screening tool (SCNS-ST9) of unmet needs in people with HGG. Routine use of this screening tool, supported by clinical pathways, may improve access to support services, potentially reducing the burden of disease for these patients.
背景
高级别胶质瘤（HGG）患者有着多样且复杂的需求。筛查旨在发现需求未得到满足且需要进行分类和进一步评估的患者。然而，由于现有大多数未满足需求的衡量指标篇幅过长，并不适用于该人群的筛查。我们旨在探讨一种简短筛查工具（SCNS - ST9）在HGG患者中检测未满足需求方面的临床效用。
方法
对一项前瞻性队列研究收集的数据进行二次分析，该研究纳入了116名HGG患者，他们在放化疗期间（T1）及6个月后（T2）完成了支持性护理需求调查（SCNS - SF34）和一项脑癌特异性需求调查（BrTSCNS）。SCNS - ST9包含来自SCNS - SF34的9个项目子集。数据分析确定了在SCNS - SF34和BrTSCNS上有未满足需求但未被SCNS - ST9识别为有某种程度需求的个体数量。
结果
总体而言，在每个时间点有3名个体（T1：2.6% [3/116]；T2：4.8% [3/63]）报告了SCNS - SF34上其他未被SCNS - ST9发现的未满足需求。特定领域的筛查项目遗漏了更高比例的个体（3.2% - 26%），尤其是在心理和卫生系统领域。总体而言，SCNS - ST9仅遗漏了1名有脑癌特异性需求的个体。
结论
研究结果证明了一种简短的未满足需求筛查工具（SCNS - ST9）在HGG患者中的敏感性和临床效用。在临床路径的支持下常规使用该筛查工具，可能会改善获得支持服务的机会， potentially reducing the burden of disease for these patients.（此处“potentially reducing...”部分原英文表述有误，正确翻译为“从而可能减轻这些患者的疾病负担”）从而可能减轻这些患者的疾病负担。
Zotero 插件